Ojo-Amaize E A, Church J A, Barka N E, Agopian M S, Peter J B
Specialty Laboratories, Inc., Santa Monica, California 90404-3900, USA.
Clin Diagn Lab Immunol. 1995 May;2(3):286-90. doi: 10.1128/cdli.2.3.286-290.1995.
Luminol-enhanced chemiluminescence (CL) of heterologous neutrophils was used to assess the capacity of a 1-ng/ml concentration of Haemophilus influenzae type b (Hib)-specific antibodies to induce opsonization of Hib with autologous heat-inactivated sera from children immunized with Hib capsular polysaccharide-polyribosylribitolphosphate (Hib-PRP) conjugate vaccine. Serum samples from 15 of 36 children (42%) vaccinated with Hib-PRP conjugate vaccine had protective levels of Hib-specific antibodies of > or = 1,000 ng/ml. Ten of these 15 (67%) had poor or nonfunctional opsonic activity. Of the 10 children whose sera lacked opsonic activity, 5 (50%) presented with recurrent Hib infection. In contrast, none of the sera of 20 healthy adults lacked opsonic capability. CL intensity was proportional to the concentration of anti-Hib antibodies used for opsonization. Furthermore, the titers of Hib-PRP-specific antibody in children and adults did not correlate with opsonic activity. These results suggest that luminol-enhanced CL as described here with minute concentrations of antibody for opsonization can be used to assess functional capacity of anti-Hib antibodies after vaccination or natural infection in the evaluation of patients with recurrent infections.
利用异源中性粒细胞的鲁米诺增强化学发光(CL)来评估浓度为1纳克/毫升的b型流感嗜血杆菌(Hib)特异性抗体,与来自接种Hib结合疫苗(Hib-聚核糖核糖醇磷酸酯,Hib-PRP)的儿童的自体热灭活血清一起诱导Hib调理作用的能力。36名接种Hib-PRP结合疫苗的儿童中有15名(42%)的血清样本中Hib特异性抗体的保护水平≥1000纳克/毫升。这15名儿童中有10名(67%)的调理活性较差或无功能。在血清缺乏调理活性的10名儿童中,有5名(50%)出现复发性Hib感染。相比之下,20名健康成年人的血清均无缺乏调理能力的情况。CL强度与用于调理的抗Hib抗体浓度成正比。此外,儿童和成年人中Hib-PRP特异性抗体的滴度与调理活性无关。这些结果表明,本文所述的使用微量抗体进行调理的鲁米诺增强CL可用于评估接种疫苗或自然感染后抗Hib抗体在复发性感染患者评估中的功能能力。